BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31847661)

  • 1. Evidence for a Direct Harmful Effect of Alcohol on Myocardial Health: A Large Cross-Sectional Study of Consumption Patterns and Cardiovascular Disease Risk Biomarkers From Northwest Russia, 2015 to 2017.
    Iakunchykova O; Averina M; Kudryavtsev AV; Wilsgaard T; Soloviev A; Schirmer H; Cook S; Leon DA
    J Am Heart Assoc; 2020 Jan; 9(1):e014491. PubMed ID: 31847661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.
    Lazo M; Chen Y; McEvoy JW; Ndumele C; Konety S; Ballantyne CM; Sharrett AR; Selvin E
    Clin Chem; 2016 Sep; 62(9):1202-10. PubMed ID: 27440513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
    Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
    Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
    Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
    J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage.
    Lakunchykova O; Averina M; Wilsgaard T; Watkins H; Malyutina S; Ragino Y; Keogh RH; Kudryavtsev AV; Govorun V; Cook S; Schirmer H; Eggen AE; Hopstock LA; Leon DA
    J Epidemiol Community Health; 2020 Sep; 74(9):698-704. PubMed ID: 32414935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained heavy drinking over 25 years is associated with increased N-terminal-pro-B-type natriuretic peptides in early old age: Population-based cohort study.
    Britton A; O'Neill D; Kuh D; Bell S
    Drug Alcohol Depend; 2020 Jul; 212():108048. PubMed ID: 32450480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
    Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
    Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biomarkers in patients with bicuspid aortic valve disease.
    Bons LR; Geenen LW; van den Hoven AT; Dik WA; van den Bosch AE; Duijnhouwer AL; Siebelink HJ; Budde RPJ; Boersma E; Wessels MW; van de Laar IMBH; DeRuiter MC; Goumans MJ; Loeys BL; Roos-Hesselink JW
    J Cardiol; 2020 Sep; 76(3):287-294. PubMed ID: 32265086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Cardiovascular Biomarkers in the Population.
    Neumann JT; Twerenbold R; Weimann J; Ballantyne CM; Benjamin EJ; Costanzo S; de Lemos JA; deFilippi CR; Di Castelnuovo A; Donfrancesco C; Dörr M; Eggers KM; Engström G; Felix SB; Ferrario MM; Gansevoort RT; Giampaoli S; Giedraitis V; Hedberg P; Iacoviello L; Jørgensen T; Kee F; Koenig W; Kuulasmaa K; Lewis JR; Lorenz T; Lyngbakken MN; Magnussen C; Melander O; Nauck M; Niiranen TJ; Nilsson PM; Olsen MH; Omland T; Oskarsson V; Palmieri L; Peters A; Prince RL; Qaderi V; Vasan RS; Salomaa V; Sans S; Smith JG; Söderberg S; Thorand B; Tonkin AM; Tunstall-Pedoe H; Veronesi G; Watanabe T; Watanabe M; Zeiher AM; Zeller T; Blankenberg S; Ojeda F
    JAMA; 2024 Jun; 331(22):1898-1909. PubMed ID: 38739396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objectively measured physical activity and cardiac biomarkers: A cross sectional population based study in older men.
    Parsons TJ; Sartini C; Welsh P; Sattar N; Ash S; Lennon LT; Wannamethee SG; Lee IM; Whincup PH; Jefferis BJ
    Int J Cardiol; 2018 Mar; 254():322-327. PubMed ID: 29407114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
    Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project.
    Takahashi Y; Satoh M; Ohmomo H; Tanaka F; Osaki T; Tanno K; Nasu T; Sakata K; Morino Y; Sobue K; Sasaki M
    Biomarkers; 2019 Sep; 24(6):566-573. PubMed ID: 30978115
    [No Abstract]   [Full Text] [Related]  

  • 16. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.